Insider · CIK 0001646754

Amin Naseem

Reports to the SEC for 2 companies · DUBLIN 2, L2

sec.gov

Transactions

Companies

Filings

CIK

0001646754

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−49.5K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2026-02-12	AVDLAVADEL PHARMACEUTICALS PLCD Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	$21.00	−$462K	0
2025-07-29	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director	AAward	+11K sh	—	—	22,000
2025-07-29	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2024-07-30	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2024-07-30	AVDLAVADEL PHARMACEUTICALS PLCA Award	Director	AAward	+11K sh	—	—	11,000
2024-05-17	AVDLAVADEL PHARMACEUTICALS PLC · Stock Option (Right to Buy)A Award	Director	AAward	+49.5K sh	—	—	49,500
2023-06-07	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+47.6K sh	—	—	291,865
2023-02-10	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+84K sh	—	—	244,287
2021-12-31	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+39K sh	—	—	160,287
2021-12-31	Bellerophon Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+8,671 sh	$3.10	+$26.9K	23,809
2020-09-10	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,509 sh	$10.12	+$65.9K	15,138
2019-09-26	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+46.3K sh	—	—	109,482
2019-01-25	Bellerophon Therapeutics, Inc.P Purchase	Director	PPurchase	+571K sh	$0.70	+$400K	1,818,867
2018-06-21	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+17.1K sh	—	—	1,247,438
2018-06-05	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+38.2K sh	$2.27	+$86.8K	83,216
2017-09-29	Bellerophon Therapeutics, Inc.P Purchase	Director	PPurchase	+456K sh	—	—	1,230,314
2017-09-29	Bellerophon Therapeutics, Inc.Common Stock Warrants (right to buy)P Purchase	Director	PPurchase	+456K sh	—	—	456,432
2017-09-22	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-06-28	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+36.2K sh	—	—	773,882
2016-11-29	Bellerophon Therapeutics, Inc.Common Stock Warrants (right to buy)P Purchase	Director	PPurchase	+714K sh	—	—	714,285
2016-11-29	Bellerophon Therapeutics, Inc.P Purchase	Director	PPurchase	+714K sh	—	—	737,650
2016-06-17	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-04-28	Bellerophon Therapeutics, Inc.A Award	Director	AAward	+23.4K sh	—	—	23,365
2015-06-29	Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Feb 124
Amin Naseem0001104659-26-014438
SEC(opens sec.gov)
Jul 314
Amin Naseem0001104659-25-072682
SEC(opens sec.gov)
Aug 14
Amin Naseem0001104659-24-084933
SEC(opens sec.gov)
May 214
Amin Naseem0001104659-24-063919
SEC(opens sec.gov)
Jun 94
Amin Naseem0001104659-23-069913
SEC(opens sec.gov)
Feb 144
Amin Naseem0001415889-23-002555
SEC(opens sec.gov)
Jan 44
Amin Naseem0001415889-22-000186
SEC(opens sec.gov)
Sep 144
Amin Naseem0001600132-20-000098
SEC(opens sec.gov)
Sep 304
Amin Naseem0001600132-19-000126
SEC(opens sec.gov)
Jan 254
Amin Naseem0001600132-19-000041
SEC(opens sec.gov)
Jun 254
Amin Naseem0001600132-18-000097
SEC(opens sec.gov)
Jun 74
Amin Naseem0001600132-18-000067
SEC(opens sec.gov)
Oct 34
Amin Naseem0001600132-17-000113
SEC(opens sec.gov)

Companies

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380